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Francisella tularensis is a highly virulent bacterial pathogen that invades and replicates within numerous host
cell types, including macrophages and epithelial cells. In an effort to better understand this process, we
screened a transposon insertion library of the F. tularensis live vaccine strain (LVS) for mutant strains that
invaded but failed to replicate within alveolar epithelial cell lines. One such strain isolated from this screen
contained an insertion in the gene FTL_1914, which is conserved among all sequenced Francisella species yet
lacks significant homology to any gene with known function. A deletion strain lacking FTL_1914 was con-
structed. This strain did not replicate in either epithelial or macrophage-like cells, and intracellular replication
was restored by the wild-type allele in trans. Based on the deletion mutant phenotype, FTL_1914 was termed
ripA (required for intracellular proliferation, factor A). Following uptake by J774.A1 cells, F. tularensis LVS
ripA colocalized with LAMP-1 then escaped the phagosome at the same rate and frequency as wild-type
LVS-infected cells. Electron micrographs of the F. tularensis LVS ripA mutant demonstrated the reentry of the
mutant bacteria into double membrane vacuoles characteristic of autophagosomes in a process that was not
dependent on replication. The F. tularensis LVS ripA mutant was significantly impaired in its ability to persist
in the lung and in its capacity to disseminate and colonize the liver and spleen in a mouse model of pulmonary
tularemia. The RipA protein was expressed during growth in laboratory media and localized to the cytoplasmic
membrane. Thus, RipA is a cytoplasmic membrane protein conserved among Francisella species that is
required for intracellular replication within the host cell cytoplasm as well as disease progression, dissemi-
nation, and virulence.
Francisella tularensis is a highly virulent zoonotic pathogen
that is the etiologic agent of the disease tularemia. Francisella
species have been isolated from over 250 animal species in-
cluding mice, rabbits, and squirrels (5). Transmission to hu-
mans from infected animals occurs through arthropod bites
(41), physical contact with infected animal tissues (10), con-
sumption of contaminated water (9, 50), or inhalation of aero-
solized organisms (19). Transmission by inhalation results in
the most aggressive form of tularemia, where as few as 10 CFU
can lead to a disease (55) that can rapidly progress (62) and
result in mortality rates as high as 60% if untreated (17).
Individual cases of tularemia occur throughout the Northern
hemisphere (35), with clusters of outbreaks occurring in Scan-
dinavia (63), Europe (28, 33), and the American Midwest (56).
Reported cases of tularemia peaked in the United States dur-
ing the 1930s and 1940s but have since declined, with only
1,368 cases reported between 1990 and 2000 (11).
F. tularensis strains infectious for humans are subdivided
into two groups, type A (Francisella tularensis subsp. tularensis)
and type B (Francisella tularensis subsp. holoarctica). Type A is
characterized by high virulence for humans and geographic
localization to North America, although recently type A was
isolated in Europe as well (29). Type B is distributed through-
out the Northern hemisphere, and infections with this strain
have an associated mortality lower than that for type A. A type
B F. tularensis strain was used to create an attenuated live
vaccine strain (LVS) for use in the Soviet Union (59); however,
this vaccine is not universally protective, nor is it licensed for
use in the United States. F. tularensis LVS is attenuated in
humans but remains pathogenic for mice and other rodents,
making it an excellent model for laboratory studies on Fran-
cisella pathogenesis (21).
F. tularensis is a facultative intracellular pathogen. The abil-
ity to replicate in various cell types such as alveolar macro-
phages (3, 45, 48, 58), dendritic cells (8), and lung alveolar type
II epithelial cells (22, 31) are all considered to be important in
the pathogenesis of Francisella. Virulence factors such as mglA
(4), iglA (16), iglC (38, 39, 54), tolC (24), clpB (42), type IV pili
(20, 23, 30), and a recently identified 58-kDa protein (60) have
all been characterized using macrophage and mouse models of
infection. Yet, the actual function of many of these proteins
remains to be determined. We screened a transposon insertion
library to identify additional genes that contribute to the in-
tracellular growth of F. tularensis. Herein, we describe one such
gene that is required for intracellular growth and virulence in
a mouse model of tularemia.
MATERIALS AND METHODS
Bacterial strains and cell culture. Escherichia coli TOP10 and M15 strains
were used for cloning and expression of six-histidine fusion proteins, respectively.
E. coli cultures were propagated in Luria broth supplemented with ampicillin at
100 g/ml or kanamycin at 20 g/ml as necessary for maintaining antibiotic
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selection. Francisella tularensis LVS was obtained from the Centers for Disease
Control and Prevention, Atlanta, GA. F. tularensis LVS was propagated on
chocolate agar (25 g/liter brain heart infusion [BHI], 50 g/ml hemoglobin, 15
g/liter agar) supplemented with 1% IsoVitaleX (Becton-Dickson), complete BHI
broth (35 g/liter BHI, 50 g/ml hemin, 1% IsoVitaleX), or Chamberlain’s de-
fined medium (12). All bacterial strains cultured on chocolate agar were grown
at 37°C. Broth cultures were incubated in a shaking water bath at 37°C.
TC-1 (ATCC CRL-2785) is a tumor cell line derived from mouse primary lung
epithelial cells that was cultured in RPMI 1640 supplemented with 2 mM L-
glutamine, 1.5 g/liter sodium bicarbonate, 10 mM HEPES, 1.0 mM sodium
pyruvate, 0.1 mM nonessential amino acids, and 10% fetal bovine serum.
J774A.1 (ATCC TIB-67) is a reticulum cell sarcoma mouse macrophage-like cell
line that was cultured in Dulbecco’s minimal essential medium with 4.5 g/liter
glucose, 2 mM L-glutamine, and 10% fetal bovine serum. Cell lines were cultured
at 37°C in a 5% CO2 atmosphere.
Plasmids and molecular techniques. Cloning of F. tularensis LVS DNA was
conducted by PCR amplification of genomic DNA by use of Pfu turbo DNA
polymerase (Stratagene) and cloned into the pCR Blunt-II TOPO vector (In-
vitrogen) by use of the manufacturer’s protocols. Plasmids for complementation
experiments were created by ligating cloned regions of the F. tularensis LVS
genome into the pKK multiple cloning site (MCS), a derivative of plasmid
pKK214 gfp (1) where a gfp Tetr fragment was removed and replaced with a
fragment containing an MCS and a Kanr allele. Kanamycin selection was main-
tained at 20 g/ml for E. coli TOP10 and 10 g/ml for F. tularensis LVS. The
kanamycin resistance gene was an F. tularensis codon-optimized version of aphA1
synthesized by Blue Heron Biotechnology that was expressed from a modified F.
tularensis groEL promoter (18).
Gentamicin protection assay. To determine the rate of intracellular invasion
and replication, F. tularensis LVS strains were cultured to mid-exponential phase
in Chamberlain’s defined medium and then added to J774A.1 or TC-1 mono-
layers at a multiplicity of infection (MOI) of 100 in 200 l of prewarmed tissue
culture medium. Gentamicin protection assays were then conducted as described
previously (31). Assays were done in triplicate and statistical significance was
determined using unpaired t tests with unequal variance on the log transforms of
recovered CFU to compare mutant strains to the wild type.
Mutagenesis and allelic exchange. A ripA deletion construct was made by
splice overlap extension (SOE) PCR (34) using primers designed to delete the
ripA locus while maintaining 1-kb flanking regions. All ripA sequence between
the start and stop codons was deleted while leaving the start and stop codons
intact. The construct was sequenced to confirm that the deletion was in frame
and to ensure the integrity of the flanking DNA sequence. A BamHI-NotI
fragment containing the deleted allele was ligated into pMP590 sacB Kanr for
allelic exchange (40). Kanamycin (10 g/ml) was used to select for plasmid
integration and 10% sucrose to counterselect for resolution as described by
LoVullo et el. (40).
Invasion and vacuolar escape assay. Intracellular bacteria accessible to cyto-
plasmically delivered antibodies were enumerated by the methods described
previously (15). The F. tularensis LVS ripA mutant’s accessibility to the cyto-
plasm was compared to that of the wild type at 20 min, 60 min, and 180 min
postinvasion into J774A.1 cells in triplicate assays per time point. Bacteria ac-
cessible to the cytoplasm were described as cytoplasmic and bacteria inaccessible
to the cytoplasm as vacuolar.
Fluorescence microscopy. J774A.1 cells were cultured in eight-well chamber
slides (Nunc). F. tularensis LVS(pKK214 gfp) and F. tularensis LVS
ripA(pKK214 gfp) were prepared for inoculation as described above. Invasion
assay synchronization, epifluorescent microscopy, and LAMP-1 colocalization
quantitation were done as described in the work of Craven et al. (15) at the
described times postinoculation into J774A.1 mouse macrophage-like cells.
Three independent assays were conducted for quantitation, with multiple cap-
tures at each time point examined. LVS green fluorescent protein (GFP)-positive
objects at 24 h contained multiple bacteria and were scored as a group. Three
independent counts of over 100 GFP-positive objects were scored as positive or
negative for LAMP-1 colocalization. The mean percentages of colocalization 
the standard deviations were recorded, and mutant values were compared to
those for the wild type with an unpaired two-tailed t test.
Electron microscopy. Monolayers of J774A.1 cells infected with LVS or the
LVS ripA mutant were rinsed with phosphate-buffered saline (PBS) and fixed
in 3% glutaraldehyde-0.15 M sodium phosphate, pH 7.4. Following three addi-
tional rinses with sodium phosphate buffer, the monolayers were postfixed for 1 h
in 1% osmium tetroxide-1.25% potassium ferrocyanide-0.15 M sodium phos-
phate buffer, rinsed in deionized water, dehydrated using increasing concentra-
tions of ethanol (30%, 50%, 75%, 100%, and 100% again for 10 min each), and
embedded in Polybed 812 epoxy resin (Polysciences, Inc., Warrington, PA). The
embedded samples were sectioned parallel and perpendicular to the substrate at
70 nm using a diamond knife. Ultrathin sections were collected on 200-mesh
copper grids and stained with 4% aqueous uranyl acetate for 15 min, followed by
Reynolds’ lead citrate for 7 min. Sections were observed using a Leo EM910
transmission electron microscope at 80 kV (LEO Electron Microscopy, Thorn-
wood, NY) and photographed using a Gatan Bioscan digital camera (Gatan, Inc.,
Pleasanton, CA).
Mouse model of pulmonary infection. Francisella strains were prepared for
intranasal inoculation by culturing in Chamberlain’s defined medium to mid-
exponential phase prior to suspension in PBS. Anesthetized 6- to 8-week-old
female C57BL/6 mice were inoculated intranasally with 105 CFU of F. tularensis
LVS suspended in 50 l of PBS. Inoculations were conducted with groups of four
mice per strain for each time point. Organ burdens were evaluated by homog-
enization and serial dilution before plating on chocolate agar to determine
recovered CFU per organ. Statistical analysis was conducted on log transforms of
organ burdens by use of independent unpaired t tests to compare mutant strains
to the wild type.
Membrane fractionation. F. tularensis LVS was cultured to mid-exponential
phase in Chamberlain’s defined medium, pelleted by centrifugation, and resus-
pended in lysis buffer (10 mM Tris, pH 7.5, 150 mM NaCl). Lysozyme was added
to 0.1 mg/ml and the bacterial suspension incubated on ice for 30 min. A 1:1 cell
suspension with 0.1-mm silica beads was beaten for 20 min in a Disruptor Genie
(Scientific Industries). Cell lysates were collected after the beads settled and the
beads were washed three times with lysis buffer. Cell lysates were clarified by
centrifugation at 12,000  g for 4 min. Crude membrane fractions were collected
by ultracentrifugation at 100,000  g for 90 min, and the supernatants were saved
as the cytosolic fractions. Crude membrane fractions were washed one time by
resuspension in lysis buffer and ultracentrifugation. Cytoplasmic membrane frac-
tions were solubilized with lysis buffer and extracted with 10% Sarkosyl (Sigma)
added to a 0.2% final concentration. Outer membrane fractions were then
pelleted by ultracentrifugation at 100,000  g for 60 min (16, 44).
Recombinant RipA and anti-RipA antiserum production. The F. tularensis
LVS ripA gene was cloned and sequenced to confirm the integrity of the DNA
sequence. The ripA allele was ligated into a pQE30 (Qiagen) vector to construct
an N-terminal six-histidine tag fusion. The ripA::6His allele was induced using 0.1
mM isopropyl--D-thiogalactopyranoside (IPTG) for 4 h and cells were har-
vested by centrifugation. The cell pellet was resuspended (40 mM Tris-HCl, pH
8.0, 1 mM EDTA, 0.1 M NaCl) and lysozyme treated at 1 mg/ml for 30 min
before sonication. The lysate was clarified by centrifugation. The crude mem-
brane fraction was pelleted by ultracentrifugation at 115,000  g for 60 min.
RipA::6His was purified from the crude membrane fraction using a Qiagen
native purification protocol with buffers containing 1% Triton X-100 and 10 mM
-mercaptoethanol. The purified RipA::6His was analyzed for purity by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Coomassie
staining. The purified protein was methanol chloroform precipitated (61) and
resuspended in PBS. Purified RipA::6His was sent to Proteintech Group, Inc.,
for the production of rabbit antiserum by the standard Proteintech long protocol.
Preimmune bleeds were collected from each rabbit used in the protocol. Anti-
serum was screened for reactivity and specificity by Western blotting of the
purified protein.
SDS-PAGE and Western analysis. SDS-PAGE was conducted by the methods
of Laemmli (36) utilizing a denaturing discontinuous 12.5% acrylamide gel.
Amounts of total protein loaded in each sample were equivalent, as determined
by a bicinchoninic acid assay (Pierce). Proteins were transferred to nitrocellulose
and blocked in 5% bovine serum albumin blocking buffer (0.05% Tween 20,
PBS) overnight. Antibody incubations were conducted in 0.5% bovine serum
albumin wash buffer (0.05% Tween 20, PBS). Membranes were washed in 0.05%
Tween 20-PBS. Primary incubations and secondary antibody incubations were
for 60 min. Rabbit anti-RipA serum was used at 1:1,000, chicken anti-AtpB
immunoglobulin Y (IgY) at 1:5,000 (AgriSera), mouse anti-GFP IgG at 1:1,000
(Abcam), goat anti-rabbit IgG–horseradish peroxidase at 1:10,000 (Sigma), and
goat anti-chicken IgG–horseradish peroxidase at 1:10,000 (Sigma). The signal
was developed using Pierce SuperSignal Pico substrate per the manufactur-
er’s protocols and detected by autoradiography.
RESULTS
Identification of RipA. To identify genes involved in Fran-
cisella intracellular growth, we created and screened a trans-
poson mutant library of F. tularensis LVS for strains that
entered but did not replicate within TC-1 cells, which are a
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transformed lung epithelial cell line. We identified one mutant
strain that invaded epithelial cells at the same frequency as F.
tularensis LVS but did not replicate following invasion (Fig.
1A). At 6 h postinoculation, there was no significant difference
between the number of CFU recovered from mutant- and
wild-type-infected TC-1 cells. However, by 24 h postinocula-
tion there were significantly fewer (P  0.001) mutant organ-
isms (1.9  105 CFU) than wild-type LVS (1.1  107 CFU)
recovered from the Tn5 mutant- and wild-type LVS-infected
cells, respectively.
To compare the levels of intracellular growth of the Tn5
mutant strain and wild-type LVS in epithelial and macrophage-
like cell lines, identical assays were performed using the
J774A.1 mouse macrophage-like cell line (Fig. 1B). As in the
TC-1 epithelial cell line, the mutant and wild-type strains en-
tered J774A.1 cells at the same frequency. At 24 h postinocu-
lation, 8.2  107 and 8.7  106 CFU (P  0.01) were recovered
from LVS- and Tn5 mutant-infected cells, respectively. Thus,
in contrast to the no-growth phenotype observed for TC-1
cells, the Tn5 mutant replicated within J774A.1 cells but to a
lesser extent than wild-type LVS. Similar results were obtained
with other lung epithelial cell lines (MLE-12, A549) and with
bone marrow-derived mouse macrophages (data not shown).
The monocyte and epithelial cell lines were propagated in
modestly different medium formulations, but swapping the me-
dia had no impact on the cell-type-specific growth defect of the
mutant (data not shown).
Analysis of the DNA sequence flanking the Tn5 insertion
showed that the interrupted allele was FTL_1914 (Fig. 2A).
This allele was termed ripA (required for intracellular prolif-
eration, factor A). The ripA locus is predicted to encode a
178-amino-acid membrane protein conserved in all sequenced
Francisella strains. There is only one copy of the locus in each
sequenced genome. pBLAST (25) was used to identify similar
non-F. tularensis proteins (E  1). These were hypothetical
membrane proteins of unknown function in Streptomyces coeli-
color A3(2) (E  1  10	10), Beggiatoa sp. strain PS (E  2 
10	10), Moritella sp. strain PE36 (E  1  10	9), Sulfitobacter
sp. strain NAS-14.1 (E  0.006), and Clostridium perfringens
type C strain JGS1495 (E  0.044), along with a predicted
membrane protein linked to a retron element in an Escherichia
coli clinical isolate (E  0.36) and a nitric oxide reductase
(NorW) in Aeromonas salmonicida (E  0.60). NorW plays a
role in nitric oxide detoxification through interactions with
NorR and NorV; however, there are no NorR or NorV ho-
mologs encoded in the Francisella genome and the amino acid
similarity is to a NorW fragment not part of the functional
oxidoreductase. Thus, at this time protein homology analyses
did not reveal any obvious clues to the function of RipA.
Creation and initial characterization of a ripA deletion mu-
tant. The intracellular growth of the LVS Tn5::ripA mutant
was not restored by in trans complementation with wild-type
ripA. Thus, to circumvent potential complications caused by
the transposon insertion, an F. tularensis LVS ripA strain
lacking all but the start and stop codons was created for use in
subsequent phenotypic assays. The deletion allele was gener-
ated by SOE PCR (Fig. 2B), cloned into the allelic exchange
vector pMP590 (40), and introduced into LVS as described
FIG. 1. Gentamicin protection assays with the LVS ripA::Tn5 mu-
tant. (A and B) TC-1 lung epithelial cells (A) or J774A.1 mouse
macrophage-like cells (B) were infected with either LVS or the LVS
ripA::Tn5 mutant at an MOI of 100. Indicated are mean CFU (n  3)
at 6 h and 24 h postinoculation with error bars  1 standard deviation.
Student’s t tests were conducted comparing LVS to the LVS ripA::Tn5
mutant at each time point (P values of 0.01 are demarcated by ).
FIG. 2. (A) Graphical representation of the genomic organization of the LVS ripA locus. Loci in close proximity to ripA (FTL_1914) on the
chromosome are FTL_1912 (30S ribosomal protein S1), FTL_1913 (Sua5/YciO/YrdC family protein), and FTL_1915 (acetyltransferase). Primers
utilized for SOE PCR are marked by arrows. int, internal; ext, external. (B) DNA sequence of the ripA deletion marked with the forward and
reverse overlapping internal primers used in the SOE PCR. The predicted ribosome binding site (RBS) and the remaining ripA codons (M and
) are marked.
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previously (27, 40). Following sucrose selection to isolate re-
solved plasmid integrants, strains lacking wild-type ripA and
possessing the ripA deletion locus were identified by PCR. The
integrity of the ripA locus and the flanking DNA was con-
firmed by sequencing. The growth of the mutant strain in
Chamberlain’s defined medium was not significantly different
from that of wild-type LVS. After 24 h of growth in Chamber-
lain’s defined medium, the mutant and wild-type strains
reached equivalent maximum densities (data not shown).
Francisella intracellular growth requires ripA. Mutant and
wild-type strains were subjected to gentamicin protection as-
says conducted with J774A.1 (Fig. 3B) and TC-1 (Fig. 3A) cell
lines to determine the contribution of ripA to intracellular
growth. The invasion frequencies of the deletion mutant were
not significantly different from those of the wild type (P 
 0.4)
in either cell line. However, in contrast to what was seen for the
wild type, the number of recovered intracellular mutant CFU
decreased after 24 h in both cell types, indicating that the
ripA mutant had an intracellular survival defect. The mean
recoveries for LVS and the LVS ripA mutant were 1.23  107
and 2.60  102 CFU (P  0.001), respectively, at 24 h for TC-1
lung epithelial cells. The mean recoveries for LVS and the LVS
ripA mutant were 1.04  108 and 1.07  105 CFU (P 
0.001), respectively, at 24 h for J774A.1 cells. The intracellular
growth defect of the LVS ripA mutant was not due to in-
creased sensitivity to gentamicin (data not shown). The intra-
cellular replication of the LVS ripA mutant was restored by in
trans complementation with ripA, demonstrating a direct
cause-and-effect relationship between ripA expression and in-
tracellular growth.
F. tularensis ripA mutant is unaffected in its ability to
escape the phagosome. Following uptake by host cells, wild-
type F. tularensis organisms escape the phagosome and repli-
cate within the cytoplasm (13, 26). With the notable exception
of F. novicida iglD (53), F. tularensis LVS purMCD (47), and
F. tularensis LVS clpB (42) mutants, most intracellular-growth-
defective mutant strains of Francisella fail to escape the phago-
some (39, 54). To determine the contribution of ripA to this
property, we compared the phagosome escape frequencies and
rates of the wild type and the ripA mutant in J774A.1 cells.
Briefly, monolayers were inoculated with GFP-expressing
strains at an MOI of 100. Invasion was synchronized as de-
scribed previously (13). Infected cells were treated with digi-
tonin to selectively permeabilize the cytoplasmic, but not the
phagosomal, membrane 20, 60, and 180 min postinvasion and
probed with Alexa 647-conjugated anti-F. tularensis antibody.
Extracellular and cytoplasmic bacteria were antibody accessi-
ble, but bacteria contained by an intact phagosomal membrane
were not. Antibody-bound and unbound organisms were quan-
tified via fluorescence-activated cell sorting, and the contribu-
tion of extracellular bacteria was accounted for in correspond-
ing samples not treated with digitonin. At each time point, the
percentages of antibody-accessible mutant and wild-type bac-
teria were statistically identical (Fig. 4A). Thus, the ripA
strain accessed the cytoplasm at the same rate as wild-type F.
tularensis LVS, demonstrating that ripA is not required for
phagosome escape and that failure to escape the phagosome
does not account for the intracellular growth defect conferred
by the ripA allele.
Francisella ripA mutant colocalizes with LAMP-1. Fran-
cisella-containing phagosomes associate with early and late
maturation antigens EEA-1 and LAMP-1 before membrane
integrity is compromised and the bacteria are released to the
cytoplasm. There is evidence to suggest that early phagosome
maturation steps are required for Francisella survival and sub-
sequent intracellular replication (17, 62). We compared mu-
tant and wild-type colocalizations with LAMP-1 in infected
cells to determine if the lack of ripA affected phagosome traf-
ficking. J774A.1 cells were inoculated with GFP-expressing
wild-type and ripA strains as described above, permeabilized,
and probed with Alexa 647-conjugated LAMP-1 antibody. The
colocalization of LAMP-1 with bacterial cells was evaluated by
epifluorescence. Consistent with what has been reported by
other groups (13, 27), at 20 and 180 min postinoculation, 50%
and 22%, respectively, of intracellular LVS colocalized with
LAMP-1 (Fig. 4B). The number of wild-type organisms colo-
calizing with LAMP-1 reached a minimum of 1.5% at 12 h
postinoculation, which was followed by an increase to 26% at
24 h (Fig. 4B). This reacquisition of LAMP-1 colocalization
has been described previously as the replication-dependent
formation of Francisella-containing vacuoles (13). The colocal-
ization of the LVS ripA mutant with LAMP-1 was not statis-
tically different from what was seen for the wild type at any
point tested (P 
 0.05; unpaired two-tailed t test), save for that
at 24 h postinoculation, when 40% of the mutant organisms
colocalized with LAMP-1. It should be noted that LVS ripA
mutant-infected cells contained only one to three bacteria per
cell, whereas wild-type-infected cells had what appeared to be
FIG. 3. Gentamicin protection assays with the ripA vector and
complemented (ripA pripA) mutants (A) TC-1 lung epithelial cells or
(B) J774A.1 mouse macrophage-like cells were infected at an MOI of
100. Indicated are mean CFU (n  3) at 6 h and 24 h postinoculation
with error bars  1 standard deviation. Student’s t tests were con-
ducted comparing strains to wild-type LVS at each time point (P values
of 0.05 are demarcated by , and P values of 0.01 are demarcated
by ).
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hundreds of bacteria 24 h postinoculation. Thus, the concen-
tration of wild-type bacteria in these cells may impact the
LAMP-1 colocalization calculations. More important than the
difference in the proportions of mutant and wild-type organ-
isms that colocalized with LAMP-1 in 24-h-infected cells is the
observation that LAMP-1 colocalization with the LVS ripA
mutant increased between 12 and 24 h. This process of reas-
sociation with LAMP-1-positive vacuoles was previously
thought to require bacterial replication (13). These results
demonstrate that replication per se is not required for this
process and that the failure to reassociate with LAMP-1-pos-
itive vacuoles does not account for the intracellular growth
deficiency of the ripA mutant.
Francisella ripA mutant reenters a membrane-bound vacuole
after escape to the cytoplasm. To confirm the intracellular
trafficking conclusions drawn from the phagosome escape and
LAMP-1 colocalization studies described above, we evaluated
mutant and wild-type subcellular localization 15 min and 3 and
24 h postinoculation by electron microscopy. Mutant and wild-
type bacteria were found in membrane-bound vacuoles at 15
min and were free in the cytoplasm at 3 h postinoculation (Fig.
5). By 24 h, bacteria within membrane-bound vacuoles were
evident. Wild-type bacteria were present at high density and
were located in either the cytosol or membrane-bound vacu-
oles. One to three mutant bacteria were present in the cytosol
or within membrane-bound vacuoles, some of which possessed
double or multiple membranes characteristic of autophago-
somes (Fig. 5).
RipA is required for virulence in a mouse model of infection.
We used a mouse model of pulmonary tularemia to assess the
role of ripA in F. tularensis virulence and pathogenesis. Anes-
thetized C57BL/6 mice were inoculated intranasally with 105
CFU of either LVS(pKK MCS) (wild type plus vector), LVS
ripA(pKK MCS) (mutant plus vector), or LVS ripA(pKK
FIG. 4. Intracellular trafficking of the LVS ripA mutant. (A) Cytoplasmic accessibility of LVS(pKK214 gfp) and LVS ripA(pKK214 gfp) in
J774A.1 macrophage-like cells at 20 min, 1 h, and 3 h postinoculation (PI). Vacuolar bacteria were defined as bacteria inaccessible to the
cytoplasmically delivered -Francisella lipopolysaccharide antibodies. Mean percentages of vacuolar (n  3) values are plotted and error bars are
representative of 1 standard deviation. The percentage of accessibility with saponin permeabilization is marked with a broken line without
symbols. (B) Colocalization of LVS(pKK214 gfp) and LVS ripA(pKK214 gfp) with LAMP-1 in J774A.1 macrophage-like cells. The percentages
of LAMP-1 colocalization were determined from three independent experiments and recorded as the mean percentages of LAMP-1 positivity, with
error bars representative of 1 standard deviation. At 24 h PI, LAMP-1 colocalization done on a per-cell basis. Individual bacteria were not
distinguishable in wild-type images. (C) Representative epifluorescent images of LVS(pKK214 gfp) and LVS ripA(pKK214 gfp) at 20 min, 3 h,
and 24 h PI in J774A.1 macrophage-like cells. The 20-min and 3-h images demonstrate similar staining patterns for LVS(pKK214 gfp) and LVS
ripA(pKK214 gfp). The 24-h image demonstrates that LVS ripA(pKK214 gfp) may be visualized as individual bacteria colocalized with LAMP-1
at this time point. Extracellular bacteria were stained with 6-(7-amino-4-methylcoumarin-3-acetyl)amino hexanoic acid and colorized blue. GFP
captures are demarcated by LVS (bottom panels) and colorized green in merged images (top panels). LAMP-1 is stained with Alexa 647 and
colorized red. Individual channels for GFP and Alexa 647 captures are marked as LVS and LAMP-1, respectively.
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MCS ripA) (mutant plus plasmid complement). Bacterial bur-
dens were measured by serial dilution and plating of homog-
enized organs. Lung burdens were determined 2 hours post-
inoculation to monitor the delivery of each strain to the lung.
Lung, liver, and spleen organ burdens (Fig. 6) were determined
1, 3, 7, and 14 days postinoculation.
The CFU recovered from the lungs at 2 h postinoculation,
2.48  104, 1.18  104, and 1.12  104 for LVS, the LVS ripA
mutant, and LVS ripA(pJRF146 ripA), respectively (Fig. 6A),
were not statistically different (P 
 0.2; independent two-tailed
t test with unequal variance); thus, equivalent numbers of each
strains were delivered to the lung. By day 1 the organ burdens
of LVS ripA mutant-infected animals were significantly lower
than those of wild-type and complemented mutant strains (P 
0.001). Within the first 24 h postinoculation, the number of
LVS ripA organisms in the lung decreased, whereas the num-
ber of both wild-type and complemented strains increased by
at least 1 order of magnitude over the number of organisms
initially delivered (Fig. 6A). In contrast to the wild-type and
complemented mutant strains, the LVS ripA mutant was not
detected in the liver or spleen before day 7 (Fig. 6B and C). At
day 7, all LVS ripA mutant-infected mice had detectable liver
burdens but only one LVS ripA mutant-infected mouse had a
detectable spleen burden (
30 CFU). In mice infected with
FIG. 5. Transmission electron microscopy of intracellular wild-type and ripA F. tularensis LVS. Individual wild-type and mutant bacteria
within membrane-bound vacuoles 20 min and 24 h postinoculation are indicated by arrows. Note the presence of multiple membranes in the 24-h
samples. Wild-type and mutant bacteria were free in the cytosol 3 h postinoculation.
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the LVS ripA mutant or with LVS ripA(pJRF146 ripA),
organ burdens were reduced at day 14 relative to day 7 (P 
0.01).
Mice infected with wild-type LVS were euthanized at day 7
due to morbidity. Collectively, these data demonstrate the im-
portance of ripA in establishing a Francisella infection.
Characterization and localization of the RipA protein. Sub-
cellular fractions of LVS, the LVS ripA mutant, and LVS
ripA(pJRF146 ripA) were analyzed by Western blotting using
anti-RipA antiserum (Fig. 7A). RipA migrated at a relative
molecular mass of 17 kDa. RipA protein was not detected in
LVS ripA lysates. Complementation with the native ripA al-
lele in a multicopy plasmid resulted in increased RipA expres-
sion relative to what was seen for the wild-type strain.
When the translated amino acid sequence was analyzed with
TopPred (14), RipA was predicted to be localized to the cyto-
plasmic membrane with three transmembrane domains and
the amino terminus in the cytoplasm. Western analysis of cy-
toplasmic, cytoplasmic membrane, and outer membrane en-
riched protein fractions (16, 44) prepared from GFP-express-
ing LVS revealed that RipA localized to the cytoplasmic
membrane (Fig. 7B). RipA was differentiated from proteins
that reacted nonspecifically with the antiserum by probing cor-
responding samples with preimmune serum. Antibodies recog-
nizing the FoF1 ATP synthase  subunit (AtpB) (37) and GFP
were used as markers for cytoplasmic membrane and cytoplas-
mic components, respectively. No GFP was detected in either
membrane fraction. Low levels of AtpB and RipA were de-
tected in the outer membrane fraction, indicating the presence
of low-level contamination with cytoplasmic membrane pro-
teins. However, the relative band intensities demonstrate that
the majority of RipA was present in the cytoplasmic membrane
fraction of F. tularensis.
DISCUSSION
The highly virulent nature of F. tularensis was recognized
even before it was isolated and identified in the 1920s as the
etiologic agent of a plague-like disease in rodents. It is evident
that the ability to survive and replicate within diverse host cell
types is fundamental to F. tularensis pathogenesis. While the
processes of host cell entry, phagosome escape, and intracel-
lular replication have been described, the mechanisms used by
FIG. 6. Bacterial organ burdens from infected mice (n  4) were
quantified as CFU per organ and graphed as individual data points.
Mean organ burdens are demarcated by horizontal broken lines. Or-
gan burdens in mice inoculated with LVS vector-only, LVS ripA
vector-only, and LVS ripA(pJRF146 ripA) (ripA pripA) strains. Lung
(A), liver (B), and spleen (C) burdens were determined at 2 h (lung
only) or at 1 day, 3 days, 7 days, and 14 days [LVS ripA vector only
and LVS ripA(pJRF146 ripA)] postinoculation. The limit of detection
is marked as a broken line at 10 CFU. Burdens that were below the
limit of detection are plotted at 10 CFU.
FIG. 7. (A) Western blot analysis of cytoplasmic membrane
enriched fractions of LVS, the LVS ripA mutant, and LVS
ripA(pJRF146 ripA) (ripA pripA). Rabbit anti-RipA (-RipA) (1:
1,000) antiserum was used as the primary antibody. (B) Subcellular
localization of RipA. Western analysis of cytosolic (Cyt.), cytoplasmic
membrane (CM), and outer membrane (OM) enriched fractions of
LVS(pKK214 gfp). Nonspecific bands were determined with preim-
mune serum from the mouse used to generate the mouse anti-RipA
serum. AtpB was used as a marker for the cytoplasmic membrane and
GFP for the cytoplasm. Specific bands (RipA, AtpB, and GFP) are
marked with black arrows. Nonspecific bands are marked with gray
arrows.
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F. tularensis to achieve these have not. The recent creation and
improvement of tools and procedures for the genetic manipu-
lation of F. tularensis have led to the identification of a number
of genes that are required for intracellular growth and/or vir-
ulence in animal models of tularemia.
We screened a transposon insertion mutant library of F.
tularensis LVS to identify previously unstudied genes required
for proliferation within host cells. One such mutant strain
contained a transposon insertion in FTL_1914 (ripA), which is
conserved among Francisella species. The transposon insertion
mutant possessed an unusual phenotype in that it failed to
replicate within cell lines of epithelial origin yet retained the
ability to replicate within monocyte cell lines and bone mar-
row-derived macrophages. We created an F. novicida U112
Tn5::ripA mutant strain by replacing the wild-type gene with
the LVS Tn5::ripA allele via homologous recombination, and
this strain had the same intracellular growth phenotype as LVS
Tn5::ripA (data not shown). However, F. tularensis LVS and
Schu S4 (data not shown) deletion mutant strains failed to
replicate in any cell type tested. We cannot account for the
differences in intracellular growth conferred by the transposon
insertion and deletion mutant alleles. Only the deletion mutant
phenotype was complemented by wild-type ripA in trans, sug-
gesting that the transposon insertion may have exerted cis-
acting or polar effects or possibly created selective pressure for
secondary unlinked mutations that compensated for the
growth defect in macrophages.
Even though ripA has homology to a limited number of
genes in other unrelated bacteria, this information does not
provide significant insight into the function of ripA. Thus, we
thoroughly characterized the expression and subcellular local-
ization of RipA, as well as the ripA mutant phenotypes, to
provide a basis for discerning the mechanism(s) by which this
protein contributes to intracellular growth.
Intracellular pathogens must overcome the host innate im-
mune response to successfully colonize the intracellular niche.
The primary host defense is centered on the antimicrobial
properties of the phagosome. Most successful intracellular
pathogens either escape the phagosome or divert phagosome
maturation to their own ends. Francisella quickly escapes the
phagosome into the cytoplasmic environment, where it repli-
cates (13, 26, 39). Since the recovery of the LVS ripA mutant
from infected epithelial cells or macrophages decreased dra-
matically after the initial invasion, we wanted to assess if the
decreased survival was due to altered intracellular trafficking of
the LVS ripA mutant. The LVS ripA mutant became acces-
sible to the cytoplasm at the same rate as wild-type LVS. The
mutant also colocalized with the late endosomal/lysosomal
marker LAMP-1 with the same frequency as the wild type.
Thus, the intracellular survival defect was not due to failure to
escape from and subsequent killing in the phagolysosome.
Autophagy is another important means by which host cells
clear pathogens from the host cytoplasm (43, 51). Most cyto-
plasmic pathogens studied to date either evade or hijack au-
tophagic mechanisms. For example, Shigella flexneri and Liste-
ria monocytogenes evade autophagy in a process requiring de
novo protein synthesis (46, 51), while Legionella pneumophila,
Salmonella enterica, and Coxiella burnetii exploit the autoph-
agic machinery (6, 7, 32, 52, 57). Francisella is different from
other intracellular pathogens that have been examined because
its evasion of autophagy is not dependent on de novo protein
synthesis (13). Francisella reenters autophagosome-like LAMP-1-
positive vacuoles after replication in the cytoplasm. The LVS
ripA mutant also localizes with LAMP-1 after escape to the
cytoplasm. Electron micrographs showed the F. tularensis LVS
ripA mutant present in vacuoles with double membranes
characteristic of autophagosomes by 24 h postinoculation. In
contrast to what has been published regarding wild-type Fran-
cisella (13), the reentry of ripA bacteria into Francisella-con-
taining vacuoles was not dependent on replication. We hypoth-
esize that the autophagy of the intracellular F. tularensis LVS
ripA mutant occurs in the cytoplasm, although this may or
may not have a direct bactericidal effect on the bacteria. Fur-
ther work needs to be done to determine if the LVS ripA
mutant requires de novo protein synthesis to stimulate com-
partmentalization during the cytoplasmic phase of its life cycle
and what effect the compartmentalization of the LVS ripA
mutant has on intracellular bacterial survival.
The survival defect of the LVS ripA mutant in the cyto-
plasm is likely due to increased sensitivity to host antimicrobial
factors, its inability to acquire a necessary nutrient, or failure to
adapt to the cytoplasmic environment. Nutritional deprivation
or auxotrophy would have a bacteriostatic effect on the bacte-
ria (2). For example, the F. tularensis purF strain, a purine
auxotroph, fails to replicate in host cell cytoplasm but persists
for an extended period before declining gradually (49). This is
not the phenotype demonstrated by the F. tularensis ripA
mutant, which declines dramatically between 6 h and 24 h in
the intracellular niche. This rapid loss of intracellular viability
coupled with the fact that the ripA strain replicates at the
same rate and extent as wild-type LVS in chemically defined
minimal Chamberlain’s medium suggests, albeit not conclu-
sively, that the F. tularensis ripA mutant is not an auxotroph.
We are currently working to determine if the ripA strain is
affected in its ability respond and adapt to the host cell cyto-
plasmic environment and are identifying RipA-interacting pro-
teins with the aim of inferring its function based on the prop-
erties of the interacting proteins.
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